Biotage – alleged patent infringement settled

Scientific Plastic Products, Inc. (“SPP”) has brought claims for infringement of U.S. Patent Nos. 8,066,875 and 8,070,957, against Biotage et alt. in a civil action entitled Scientific Plastic Products, Inc. v. Biotage AB, et al. (“Defendants”), pending in the United States District Court for the Southern District of California (the “Lawsuit”). The matter has been amicably resolved and the Lawsuit has been dismissed. Defendants have not agreed to any liability and no claim remains pending against Defendants. The terms of settlement are confidential.

Contact persons:
Torben Jörgensen, CEO
Tel: 0707-49 05 84, torben.jorgensen@biotage.com

This information is information that Biotage AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 08.30 CET on August 16, 2017.

About Biotage

Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan and South Korea. Biotage has approx. 300 employees and had sales of 667 MSEK in 2016. Biotage is listed on the NASDAQ OMX Nordic. Website: www.biotage.com

Tags: